Work

Abstract 682: Development of novel eIF4E inhibitors to potently and selectively suppress tumor growth across multiple indications

Year: 2024

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2024-682

Authors: Matthew B. Friedersdorf, Devon R. Blake, Sarah E. Thompson, Roheeth Pavana, Ramamurty V. Changalvala, Andrew S. Truong, Krista Marran, Abha Bias, Jessica A. Sorrentino

Institution: Ribometrix (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4393088529

Cites:

Cited by:

Related to: 10